The effect of tofacitinib on function and quality of life indicators in patients with rheumatoid arthritis resistant to synthetic and biological disease-modifying antirheumatic drugs in real clinical practice: Results of a multicenter observational study

Tofacitinib (TOFA), a representative of a new class of targeted synthetic disease-modifying antirheumatic drugs (s-DMARD), is a promising drug for treating rheumatoid arthritis (RA) and other immune inflammatory diseases.Objective: to evaluate the efficiency and safety of therapy with TOFA in combin...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. E. Karateev, D. E. Abdulganieva, A. R. Babaeva, A. A. Baranov, L. P. Evstigneeva, O. N. Ivanova, G. V. Lukina, E. L. Luchikhina, V. I. Mazurov, A. S. Misiyuk, O. V. Semagina, A. E. Sizikov, V. N. Sorotskaya
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2017-03-01
Series:	Современная ревматология
Subjects:	rheumatoid arthritis functional ability quality of life tofacitinib.
Online Access:	https://mrj.ima-press.net/mrj/article/view/732
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

The effect of tofacitinib on function and quality of life indicators in patients with rheumatoid arthritis resistant to synthetic and biological disease-modifying antirheumatic drugs in real clinical practice: Results of a multicenter observational study

Similar Items